- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular risk and obesity
Authors
Keywords
Obesity, Cardiovascular risk, Clinical assessment
Journal
Diabetology & Metabolic Syndrome
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-28
DOI
10.1186/s13098-019-0468-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State-of-the-art review article atherosclerosis affecting fat: What can we learn from perivascular adipose tissue?
- (2019) Charalambos Antoniades et al. Journal of Cardiovascular Computed Tomography
- Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients–Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial
- (2018) Erin A. Bohula et al. AMERICAN HEART JOURNAL
- Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
- (2018) Dorrin Zarrin Khat et al. Current Diabetes Reports
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Adipokine dysregulation and adipose tissue inflammation in human obesity
- (2018) Xabier Unamuno et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
- (2018) Erin A. Bohula et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies
- (2018) I. C. L. van den Munckhof et al. Obesity Reviews
- Obesity Pathogenesis: An Endocrine Society Scientific Statement
- (2017) Michael W Schwartz et al. ENDOCRINE REVIEWS
- C-reactive protein in Brazilian adolescents: distribution and association with metabolic syndrome in ERICA survey
- (2017) D T Giannini et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review
- (2017) Adriana J. van Ballegooijen et al. International Journal of Endocrinology
- Inflammatory activity of adipose tissue
- (2017) Şahin İşcan Anatolian Journal of Cardiology
- JNK at the crossroad of obesity, insulin resistance, and cell stress response
- (2017) Giovanni Solinas et al. Molecular Metabolism
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
- (2016) Olivia M. Farr et al. DIABETOLOGIA
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond
- (2016) A. L. João et al. Obesity Reviews
- Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity
- (2015) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance andβ-Cell Dysfunction
- (2015) Kevin Noel Keane et al. Oxidative Medicine and Cellular Longevity
- Relationship between adiponectin, obesity and insulin resistance
- (2015) Guilherme Ardenghi Balsan et al. Revista da Associacao Medica Brasileira
- Perivascular Adipose Tissue and Coronary Vascular Disease
- (2014) Meredith Kohr Owen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New and emerging regulators of intestinal lipoprotein secretion
- (2014) Changting Xiao et al. ATHEROSCLEROSIS
- Leptin Mediates the Increase in Blood Pressure Associated with Obesity
- (2014) Stephanie E. Simonds et al. CELL
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of adipose tissue immune cells in obesity and low-grade inflammation
- (2014) Milos Mraz et al. JOURNAL OF ENDOCRINOLOGY
- The impact of obesity on subclinical coronary atherosclerosis according to the risk of cardiovascular disease
- (2014) Seung-Yul Lee et al. Obesity
- The Epidemiology of Obesity: A Big Picture
- (2014) Adela Hruby et al. PHARMACOECONOMICS
- Obesity: Pathophysiology and Intervention
- (2014) Yi Zhang et al. Nutrients
- Ghrelin
- (2013) Geetali Pradhan et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Metabolically Healthy Obesity and Risk of Mortality: Does the definition of metabolic health matter?
- (2013) G.-M. Hinnouho et al. DIABETES CARE
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Metabolically healthy obesity: Definitions, determinants and clinical implications
- (2013) Catherine M. Phillips REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
- (2013) Heriberto Rodríguez-Hernández et al. International Journal of Endocrinology
- Mechanisms of Inflammatory Responses in Obese Adipose Tissue
- (2012) Shengyi Sun et al. Annual Review of Nutrition
- The incretin system and cardiometabolic disease
- (2011) Paul E. Szmitko et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Obesidade e doença arterial coronariana: papel da inflamação vascular
- (2010) Fernando Gomes et al. Arquivos Brasileiros de Cardiologia
- Progressos recentes e novas perspectivas em farmacoterapia da obesidade
- (2010) André M. Faria et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome
- (2008) Peter J. Turnbaugh et al. Cell Host & Microbe
- Impact of Obesity on Cardiovascular Disease
- (2008) Kerstyn C. Zalesin et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Obesity: Effects on Cardiovascular Disease and its Diagnosis
- (2008) B. Mathew et al. Journal of the American Board of Family Medicine
- Which Measures of Obesity Best Predict Cardiovascular Risk?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2008) Sheldon E. Litwin JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation